WOBURN, Mass. , Dec. 02, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that Meghna Malik , Ph.D., Senior Director, will present at the 4 th CRISPR AgBio Congress which is being held December 1-3, 2020 as a virtual event. Dr.
WOBURN, Mass. , Nov. 12, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today reported financial results for the three and nine months ended September 30, 2020 . "We are very pleased with our strong progress across multiple fronts in the third
WOBURN, Mass. and HARPENDEN, U.K. , Nov. 12, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced it has signed a collaboration agreement with UK -based Rothamsted Research to support Rothamsted’s Flagship Program to develop omega-3
WOBURN, Mass. , Nov. 05, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), an agricultural bioscience company, announced today that the Company will report its third quarter 2020 financial results and provide a corporate update on Thursday, November 12, 2020 .
WOBURN, Mass. , Oct. 28, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that it has begun field testing to evaluate the emergence and agronomics of winter Camelina sativa varieties.
WOBURN, Mass. , Oct. 01, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced it has completed the harvest for its 2020 Field Test Program for Camelina and canola trials conducted in the United States and Canada .
WOBURN, Mass. , Sept. 09, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced it will be featured as a presenting company at the H.C. Wainwright 22nd Annual Global Investment Conference .
WOBURN, MA / ACCESSWIRE / August 27, 2020 / Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company, today announced that Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will give a virtual corporate presentation at the LD 500 Virtual Conference on
WOBURN, Mass. , Aug. 26, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced the closing of its previously announced underwritten public offering of 835,000 shares of its common stock at a public offering price of $4.25 per share.
WOBURN, Mass. , Aug. 22, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced the pricing of its underwritten public offering of 835,000 shares of its common stock at a public offering price of $4.25 per share.
WOBURN, Mass. , Aug. 21, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced it has commenced an underwritten public offering of shares of its common stock. Yield10 also plans to enter into a separate securities purchase agreement
WOBURN, Mass. , Aug. 17, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that it has obtained a positive response from USDA-APHIS’s Biotechnology Regulatory Services (BRS) for its CRISPR genome-edited trait C3007 in canola plant
WOBURN, Mass. , Aug. 11, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today reported financial results for the three and six months ended June 30, 2020 . "The Yield10 team has made good progress executing on our strategic plans for 2020 and
WOBURN, Mass. and GIBSON CITY, Ill. , Aug. 11, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that it has signed a three-year non-exclusive research agreement with GDM (“GDM”), a company specialized in plant genetics based in
WOBURN, Mass. , Aug. 06, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), an agricultural bioscience company, announced today that the Company will report its second quarter 2020 financial results and provide a corporate update on Tuesday, August 11, 2020 .
WOBURN, Mass. , Aug. 05, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that it established 50 acres of spring Camelina under contract with a grower in Montana in the second quarter of 2020.
WOBURN, Mass. , Aug. 04, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that it conducted field testing during the 2019/2020 winter season to evaluate emergence of winter Camelina sativa varieties.
WOBURN, Mass. , June 17, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced it has begun its 2020 Field Test Program based on the recent completion of planting at all sites contracted for the trials in the United States and Canada
WOBURN, Mass. , May 14, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today reported financial results for the three months ended March 31, 2020 . “In the first quarter, we prioritized focus on activities relating to our 2020 Field Testing
WOBURN, Mass. , May 14, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that the Company has secured all of the regulatory permits required to conduct field tests for multiple traits at sites in the United States and Canada
